GeneGene: FCGRT

Neonatal Fc receptor (FcRn)

FcRn (encoded by FCGRT) recycles IgG antibodies and extends their half-life. Blocking FcRn accelerates the clearance of pathogenic IgG autoantibodies, a mechanism used to treat antibody-mediated autoimmune diseases such as thyroid eye disease and myasthenia gravis.

1
Drugs
1
Trials tracked
0
Resolved
1
Indications

Drugs hitting this target

Trials targeting FcRn

1 benchmark

Indications

About FcRn

What is FcRn?

FcRn (encoded by FCGRT) recycles IgG antibodies and extends their half-life. Blocking FcRn accelerates the clearance of pathogenic IgG autoantibodies, a mechanism used to treat antibody-mediated autoimmune diseases such as thyroid eye disease and myasthenia gravis.

Which drugs target FcRn?

Therapies acting on FcRn tracked here include Efgartigimod.

References